CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.
about
Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1Protein kinase C theta is not essential for T-cell-mediated clearance of murine gammaherpesvirus 68.Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40.CD4 T-cell help programs a change in CD8 T-cell function enabling effective long-term control of murine gammaherpesvirus 68: role of PD-1-PD-L1 interactions.B cell-specific expression of B7-2 is required for follicular Th cell function in response to vaccinia virus.CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68.CD8+ T cell dysfunction and increase in murine gammaherpesvirus latent viral burden in the absence of 4-1BB ligandMultiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunityThe role of apoptosis in the development and function of T lymphocytes.CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68.Primary clearance of murine gammaherpesvirus 68 by PKCtheta-/- CD8 T cells is compromised in the absence of help from CD4 T cells.Preferential use of B7.2 and not B7.1 in priming of vaccinia virus-specific CD8 T cells.Differential requirement for CD28 and CD80/86 pathways of costimulation in the long-term control of murine gammaherpesvirus-68.
P2860
Q33484744-48A8F86B-4E95-4873-8134-6B6D40DE894BQ33788837-8EDF0DB5-F5D4-4672-9550-2F08EB448117Q33834753-9B8ABC45-C4D6-4915-A6A9-F2789CE5D4EDQ34046167-933F3EC2-5FB5-4E7C-9C91-8549575B4C2BQ34950531-B0305757-0E79-436B-B7C2-5F1B4E64A24EQ35024341-59ACB993-FFD2-4CB8-9A38-A6164E1A65F0Q35478892-08374D32-EE02-4041-83B9-634C254F2375Q35826538-7689A00B-C3B3-41E8-9EE7-4EE910D6F4B4Q36295655-EAF12FC6-C0C1-4C58-B0EE-1F9521ABDC7CQ36949825-85D93AF2-AF97-4783-B223-F3A1AEC00496Q36974702-B51843AE-6A47-4BF8-A6C8-C441CFD39F3BQ37255184-0CE15E86-9B9B-4DD4-AEA7-05EA7338D2D3Q41857406-A61818FB-5CA8-4566-B49E-6B35683EDB0B
P2860
CD28(-/-) mice show defects in cellular and humoral immunity but are able to control infection with murine gammaherpesvirus 68.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@ast
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@en
type
label
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@ast
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@en
prefLabel
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@ast
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@en
P2093
P2860
P1433
P1476
CD28(-/-) mice show defects in ...... th murine gammaherpesvirus 68.
@en
P2093
Bong Joo Lee
Mandy Anderson
Sally R Sarawar
Su Khoh Reiter
P2860
P304
P356
10.1128/JVI.76.6.3049-3053.2002
P407
P577
2002-03-01T00:00:00Z